Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00353483 · ClinicalTrials.gov registry record
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
A clinical trial of Breast Neoplasms, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT00353483 is a study of Breast Neoplasms that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 300 participants, below the 566-participant average among 97 other Breast Neoplasms trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00353483, a study of Breast Neoplasms, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of this study is to compare genetic markers present on tumor cells before and after chemotherapy.
Conditions Studied
Interventions
- PROCEDURE Peripheral blood draw
- PROCEDURE Breast tissue collection
- PROCEDURE Bone marrow biopsy
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2005-09-14 |
| Est. Completion | 2026-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00353483
The ClinicalTrials.gov registry entry for NCT00353483 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 566-participant average among 97 other Breast Neoplasms trials with a reported enrollment target (47% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Neoplasms appearing as the primary indexed condition, and to 3 interventions - of which Peripheral blood draw is the first listed.
NCT00353483 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT00353483 about?
NCT00353483 is a clinical study titled "Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells". The main purpose of this study is to compare genetic markers present on tumor cells before and after chemotherapy.
What is the current status of trial NCT00353483?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2005-09-14. Estimated completion is 2026-08-31.
What conditions does trial NCT00353483 study?
This clinical trial studies the following conditions: Breast Neoplasms.
What interventions are being tested in trial NCT00353483?
The interventions under investigation include: Peripheral blood draw (PROCEDURE), Breast tissue collection (PROCEDURE), Bone marrow biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00353483?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00353483 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
RECRUITING · Phase 2
-
Focused Ultrasound and Gemcitabine in Breast Cancer
RECRUITING · Phase 1
-
A Registry Study of Breast Microseed Treatment
RECRUITING
-
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RECRUITING · Phase 1
-
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RECRUITING · Phase 3
-
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.